As experts in radioisotopes,
we are committed to enhancing human health
and advancing medical care
News
-
-
2026.09.18InformationAnnouncement of a Presentation at ESRAH 2026
-
2026.08.24InformationAnnouncement of Presentations at PET Summer Seminar 2026 in Nagasaki
-
2026.08.18InformationArticle Published in the Journal of the Particle Accelerator Society of Japan
-
2026.08.13InformationPeptiDream CEO Patrick Reid Featured in Nikkei’s “Business TODAY”
-
2026.07.13Press ReleasePeptiDream Announces First Patient Dosed in Phase 1 Trial of First Wholly-Owned Radiopharmaceutical Program Targeting Carbonic Anhydrase IX (CA9) for Kidney Cancer（PeptiDream Inc. ）
-
Who We Are
VIEW MOREOur mission is to discover the next generation of transformational medicines for patients worldwide.
Since our founding in 1968, PDRadiopharma Inc. has supported the advancement of nuclear medicine by reliably supplying diagnostic and therapeutic radiopharmaceuticals.
Leveraging our extensive expertise in diagnostic radiopharmaceuticals, we are expanding our therapeutic portfolio and advancing theranostics to contribute to the evolution of precision medicine.
Our Business
As a pioneer in radiopharmaceuticals, we deliver
innovation from diagnosis to therapy.
From research and development through manufacturing and supply, we support high-quality diagnosis and therapy with cutting-edge solutions.
As a total solutions provider in nuclear medicine, PDRadiopharma continues to shape the future of healthcare and contribute to society.
-
R&D
Explore our research and development capabilities, pipeline, and clinical trials that are advancing radiopharmaceuticals for diagnosis and therapy.
VIEW MORE -
Manufacturing & Supply
Learn about our manufacturing and supply capabilities that support the reliable delivery of radiopharmaceuticals for diagnosis and therapy.
VIEW MORE -
Total Solutions for
RI Diagnosis and RI TherapyDiscover our comprehensive solutions that support healthcare professionals through the nuclear medicine workflow, including administration and operational support, radiation dose management, and image analysis software.
VIEW MORE
About Radiopharmaceuticals
Radioisotope-based diagnosis and therapy hold great potential for advancing healthcare. Learn about these technologies, their growth potential and future prospects.
VIEW MORE